Institutional Ownership C4 Therapeutics, Inc. (CCCC)
This table provides information about the institutional ownership of C4 Therapeutics, Inc. (CCCC). We have compiled data on the 126 institutions that hold shares in the stock, with a total of 63 Million shares, which have been reported (via 13F filing form) to have a value of $188 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
6,978,942
shares
|
$21 Million
1.75% of portfolio
|
Q4 2024
Added 5.68%
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
Feb 14, 2025 Q4 2024 |
6,852,744
shares
|
$20.6 Million
9.58% of portfolio
|
Q4 2024
Reduced 0.4%
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
6,072,601
shares
|
$18.3 Million
0.11% of portfolio
|
Q4 2024
Added 6.96%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,878,000
shares
|
$14.7 Million
0.28% of portfolio
|
Q2 2024
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,551,510
shares
|
$13.7 Million
0.0% of portfolio
|
Q2 2024
Added 402.93%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
4,377,900
shares
|
$13.2 Million
0.43% of portfolio
|
Q3 2024
Added 189.34%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
3,839,469
shares
|
$11.6 Million
0.0% of portfolio
|
Q4 2024
Added 65.06%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,345,973
shares
|
$10.1 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.73%
|
|
|
Samlyn Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
3,019,458
shares
|
$9.09 Million
0.18% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,677,642
shares
|
$5.05 Million
0.0% of portfolio
|
Q4 2024
Reduced 17.61%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,550,000
shares
|
$4.67 Million
0.01% of portfolio
|
Q4 2024
Added 198.08%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,381,086
shares
|
$4.16 Million
0.0% of portfolio
|
Q4 2024
Added 0.83%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Feb 14, 2025 Q4 2024 |
1,334,101
shares
|
$4.02 Million
0.07% of portfolio
|
Q4 2024
Added 1.11%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,223,018
shares
|
$3.68 Million
0.0% of portfolio
|
Q4 2024
Reduced 56.43%
|
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
1,221,131
shares
|
$3.68 Million
1.06% of portfolio
|
Q4 2024
Added 6.38%
|
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,111,910
shares
|
$3.35 Million
1.08% of portfolio
|
Q2 2024
Reduced 2.65%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
900,000
shares
|
$2.71 Million
0.24% of portfolio
|
Q4 2024
Added 28.57%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
884,300
shares
|
$2.66 Million
0.01% of portfolio
|
Q4 2024
Reduced 17.01%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
757,852
shares
|
$2.28 Million
0.0% of portfolio
|
Q4 2024
Added 126.85%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
573,655
shares
|
$1.73 Million
0.0% of portfolio
|
Q4 2024
Added 13.4%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
563,837
shares
|
$1.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 31.94%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
523,931
shares
|
$1.58 Million
0.0% of portfolio
|
Q4 2024
Reduced 9.49%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
495,043
shares
|
$1.49 Million
0.0% of portfolio
|
Q4 2024
Added 1.07%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
486,366
shares
|
$1.46 Million
0.0% of portfolio
|
Q4 2024
Added 0.71%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
360,125
shares
|
$1.08 Million
0.0% of portfolio
|
Q4 2024
Added 1548.32%
|